About
PTC Therapeutics is a global biopharmaceutical company that discovers, develops, and commercializes medicines targeting rare and serious genetic disorders such as Duchenne muscular dystrophy, phenylketonuria, and other neuromuscular and metabolic diseases.
Explore PTC Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.